
ABOUT US
Repligen is a bioprocessing-focused life sciences company bringing over 40 years of expertise and innovation to our customers. We are inspiring advances in bioprocessing through the development and commercialization of high-value products and flexible solutions that address critical steps in the production of biologic drugs, principally monoclonal antibodies.
Repligen headquarters is in Waltham, Massachusetts and our manufacturing facilities are located around the world. We market our products globally through a direct commercial organization in the U.S., Europe and Asia, as well as through strategic partners in select markets.
FEATURED INSIGHTS
-
Streamline viral vector manufacturing with perfusion technologies that reduce costs and improve scalability. Discover how a tangential flow depth filtration system enhances yield and quality.
-
Scaling gene therapies beyond rare diseases demands innovation. Discover a chromatography system that boosts efficiency, protects product integrity, and overcomes viral vector manufacturing challenges.
-
Discover how hollow fiber tangential flow filtration enhances downstream bioprocessing with efficient ultrafiltration and diafiltration, reduced fouling, and scalable performance.
-
Gene therapy is revolutionizing medicine to offer one-time treatments. Find out how AAV vectors are leading the way to optimize production and make these life-changing therapies accessible.
-
Hear firsthand insights from experts to discover how a TFF system empowers bioprocessing teams—from start-ups to global leaders—with unmatched reliability and flexibility.
-
Optimize your plasmid DNA workflows with insights from Forge Biologics. Discover how TFF advancements cut processing time by 300% while improving RNA removal and DNA quality.
-
Feed consistency is crucial to TFF performance, yet often overlooked. Discover how improved mixing dynamics using an innovative system can enhance filtration efficiency and reliability.
-
Not all TFF systems are created equal. Explore how automated solutions eliminate manual chaos, improve reproducibility, and scale with ease.
-
Learn more about a single-use film that is engineered for durability and minimal extractables to enhance efficiency, reliability, and product quality across diverse applications and environments.
-
Discover how to prepare 10x PBS using an innovative system to ensure scalable, efficient, and consistent buffer preparation for large-scale workflows.
-
Streamline protein and antibody purification with an automated TFF system featuring real-time, in-line concentration measurement for enhanced accuracy, reliability, and cGMP compliance.
-
Discover a novel analytical method enhancing TFF diafiltration insights that deliver superior mixing, reliable scale-up, and breakthrough interpretation of diavolume performance.
-
Antibody-drug conjugates offer targeted cancer treatment with reduced toxicity. Discover how single-use technologies simplify ADC manufacturing to ensure safety, flexibility, and efficiency.
-
Continuous bioprocessing is revolutionizing biotherapeutic manufacturing. Gain expert insights about cutting-edge innovations in monoclonal antibody production that enable scalable solutions for next-gen therapies.
-
Demand for EVs is rising due to their therapeutic promise. Explore two scalable platforms that address production challenges to support EVs' expanding clinical and commercial applications.
-
Explore a scalable, sterile solution for isolating extracellular vesicles (EVs) in exosome therapeutics to enhance yield, purity, and commercial viability through innovative filtration technology.
-
Address the rising gene therapy demands with an innovative perfusion strategy that significantly boosts cell density and viral vector yields to pave the way for scalable, efficient manufacturing.
-
Discover how TFDF-based perfusion technology boosts lentiviral vector production by over 10-fold, slashes costs, and accelerates the commercialization of CAR-T and other advanced cell therapies.
-
Learn how Tangential Flow Depth Filtration (TFDF) enhances viral vector production, streamlining the clarification process and increasing efficiency and yield for LV and AAV manufacturing.
-
The demand for complex biologics is driving the need for intensified cell culture technologies. Perfusion using ATF has emerged as a leading solution to increase cell density and productivity.
CONTACT INFORMATION
Repligen
41 Seyon Street, Building 1, Suite 100
Waltham, MA 02453
UNITED STATES
Phone: 781-250-0111
USER WORKSHOP AND DISCUSSION: ADCS – EXPERT PERSPECTIVES ON EFFICIENCY, SAFETY AND INNOVATION
As ADC development evolves, so do the manufacturing challenges—demanding greater precision, safety, and scalability. From containment to mixing and fill-finish, every step requires advanced solutions.
Join us for our free, exclusive one-day, in-person gathering of senior Process Development and MSAT professionals, designed to deliver actionable insights and forge connections among the industry’s technical leaders.
SOLUTIONS
-
Discover how innovative solutions can reduce production time, cut costs, and improve yields to ensure exceptional product quality at every stage of biologic drug development.
-
Engineered for biotech and biopharma, discover a single-use mixer that uses advanced technology to deliver scalable, sterile, and efficient mixing for critical cleanroom applications.
-
Learn about a system that enables simple, fast, cost-effective, and scalable upstream intensification development. It delivers precise flow rates, even at high cell densities and viscosities.
-
Learn about innovative cell retention technology that supports continuous bioprocessing through perfusion cell culture, allowing for longer run times, higher product yields, and reduced costs.